SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM NEW
Total 13F shares
55,009
Share change
-21,255
Total reported value
$269,000
Put/Call ratio
300%
Price per share
$4.00
Number of holders
8
Value change
-$206,000
Number of buys
2
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q2 2021

As of 30 Jun 2021, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,009 shares. The largest 8 holders included Cutler Group LP, Stratos Wealth Partners, LTD., GWM Advisors LLC, Arkadios Wealth Advisors, WELLS FARGO & COMPANY/MN, TSFG, LLC, OSAIC HOLDINGS, INC., and IFP Advisors, Inc. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.